Literature DB >> 22099031

Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series.

Firas Abdollah1, Cesare Cozzarini, Nazareno Suardi, Andrea Gallina, Umberto Capitanio, Marco Bianchi, Manuela Tutolo, Andrea Salonia, Mariangela La Macchia, Nadia Di Muzio, Patrizio Rigatti, Francesco Montorsi, Alberto Briganti.   

Abstract

PURPOSE: Previous studies have criticized the predicting ability of the Roach formula in assessing the risk of lymph node invasion (LNI) in contemporary patients with prostate cancer (PCa) due to a significant overestimation of LNI rates. However, all those studies included patients treated with limited pelvic lymph node dissection (PLND), which is associated with high rates of false negative findings. We hypothesized that the Roach formula is still an accurate tool for LNI predictions if an extended PLND (ePLND) is performed. METHODS AND MATERIALS: We included 3,115 consecutive patients treated with radical prostatectomy and ePLND between 2000 and 2010 at a single tertiary referral center. Extended PLND consisted of removal of obturator, external iliac, and hypogastric lymph nodes. We externally validated the Roach formula by using the area under the receiver operating characteristics curve and calibration plot method. Moreover, we tested the performance characteristics of different formula-generated cutoff values ranging from 1% to 20%.
RESULTS: The accuracy of the Roach formula was 80.3%. The calibration showed only a minor underestimation of the LNI risk in high-risk patients (6.7%). According to the Roach formula, the use of 15% cut off would have allowed 74.2% (2,311/3,115) of patients to avoid nodal irradiation, while up to 32.7% (111/336) of all patients with LNI would have been missed. When the cut off was lowered to 6%, nodal treatment would have been spared in 1,541 (49.5%) patients while missing 41 LNI patients. The sensitivity, specificity, and negative predictive values associated with the 6% cut off were 87.9%, 54%, and 97.3%, respectively.
CONCLUSIONS: The Roach formula is still accurate and does not overestimate the rate of LNI in contemporary prostate cancer patients if they are treated with ePLND. However, the recommended cut off of 15% would miss approximately one-third of patients with LNI. Based on our results, the cut off should be lowered to 6%.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22099031     DOI: 10.1016/j.ijrobp.2011.06.2014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer.

Authors:  Michael Pinkawa; Vanessa Berneking; Liane König; Dilini Frank; Marilou Bretgeld; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2016-09-08       Impact factor: 3.621

2.  Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.

Authors:  Changhoon Song; Hyun-Cheol Kang; Jae-Sung Kim; Keun-Yong Eom; In Ah Kim; Jin-Beom Chung; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee
Journal:  Strahlenther Onkol       Date:  2015-07-10       Impact factor: 3.621

3.  The Roach Equation: Value of Old Clinical Tools in the Era of New Molecular Imaging.

Authors:  Yun Rose Li; Mack Roach
Journal:  J Nucl Med       Date:  2020-05-22       Impact factor: 11.082

Review 4.  A narrative review of pelvic lymph node dissection in prostate cancer.

Authors:  Douglas C Cheung; Neil Fleshner; Shomik Sengupta; Dixon Woon
Journal:  Transl Androl Urol       Date:  2020-12

5.  Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy.

Authors:  Mike Wenzel; Felix Preisser; Benedikt Hoeh; Maria N Welte; Clara Humke; Clarissa Wittler; Christoph Würnschimmel; Andreas Becker; Pierre I Karakiewicz; Felix K H Chun; Philipp Mandel; Luis A Kluth
Journal:  Front Surg       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.